Keywords :
Alleles; Cell Line, Tumor; DNA, Complementary/genetics; Humans; Lung Neoplasms/pathology; Mutation; RNA, Messenger/genetics; Receptor, Epidermal Growth Factor/genetics; Reverse Transcriptase Polymerase Chain Reaction; Time Factors
Abstract :
[en] A simple and sensitive real-time reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) was developed to quantify threonine-to-methionine substitution at amino acid position 790 (T790M) mutant transcripts in a wild-type (wt) epidermal growth factor receptor background. The assay is based on three unmodified oligonucleotides, and both SYBR Green and a Taqman probe can be used. To increase the discrimination between mutant and wt signals, ARMS (amplification refractory mutation system) and LNA (locked nucleic acid) primers were tested, but a benefit was observed only with plasmids and not with cellular complementary DNA. The RT-qPCR assay using transcript-specific primers can detect as few as 1% T790M transcripts in a wt background and, therefore, will be useful in RNA interference studies specifically targeting mutant RNA.
Scopus citations®
without self-citations
9